Skip to main content

and
  1. No Access

    Article

    Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer

    The combination of abiraterone acetate and prednisone (AA/P) is used to treat metastatic prostate cancer, but molecular predictors of treatment response are not well elucidated. We evaluated plasma circulating...

    Meijun Du, Yijun Tian, Winston Tan, Liewei Wang in Prostate Cancer and Prostatic Diseases (2020)

  2. No Access

    Article

    Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

    The prognostic significance of plasma cell-free DNA (cfDNA) androgen receptor amplification (ARamp) in metastatic castration-resistant prostate cancer (mCRPC) compared with circulating tumor cell (CTC) counts is ...

    Manish Kohli, Jian Li, Meijun Du, David W Hillman in Prostate Cancer and Prostatic Diseases (2018)